ISRG vs SYK vs EW Stock Comparison

Intuitive Surgical, Stryker and Edwards Lifesciences Prices as of Nov 13, 2026 Peers: Industry group
ISRG Intuitive Surgical Inc
$443.59 +5.6% 1M -21.6% 1Y
Market cap
$152.73B
P/E
51.6x
Revenue (TTM)
$11.58B
Div. yield
–
Medical Devices Healthcare
5 wins
SYK Stryker Corp
$309.54 +9.9% 1M -17.1% 1Y
Market cap
$118.57B
P/E
32.7x
Revenue (TTM)
$26.30B
Div. yield
–
Medical Devices Healthcare
3 wins
EW Edwards Lifesciences Corp
$107.18 +24.0% 1M +24.5% 1Y
Market cap
$61.58B
P/E
60.7x
Revenue (TTM)
$6.67B
Div. yield
–
Medical Devices Healthcare
3 wins

Head to Head

11 decided of 12

Intuitive Surgical leads on 5 of the 12 questions below (Intuitive Surgical 5, Stryker 3, Edwards Lifesciences 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionISRGSYKEWLeader
Larger companyMarket capitalisation $152.73B $118.57B $61.58B ISRG
Cheaper on earningsLower P/E, profitable companies only 51.6x 32.7x 60.7x SYK
Cheaper on forward earningsLower price / next fiscal year consensus EPS 38.5x 19.6x 37.6x SYK
Faster revenue growthRevenue growth, trailing twelve months +20.5% +7.9% +13.4% ISRG
More profitableNet margin, trailing twelve months 25.5% 13.8% 15.2% ISRG
Better return on capitalReturn on invested capital — 10.0% 8.7% SYK
Less leveragedLower net debt / EBITDA — 3.5x -2.5x EW
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -21.6% -17.1% +24.5% EW
Better 5-year returnAnnualised price return, 5 years +4.6%/yr +3.2%/yr -1.6%/yr ISRG
Less volatileAnnualised volatility, 1 year 36.1% 32.9% 25.5% EW
Higher overall scoreMean of the five percentile scores vs peers 81/100 67/100 77/100 ISRG

Percentile Scorecard

ISRGSYKEW

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisISRGSYKEW
Valuation 52 #118 of 243 66 #84 of 243 61 #96 of 243
Growth 81 #45 of 228 63 #85 of 228 57 #99 of 228
Profitability 97 #7 of 222 88 #28 of 222 96 #10 of 222
Financial Health 81 #47 of 248 42 #144 of 248 87 #34 of 248
Shareholder Returns 95 #9 of 158 78 #35 of 158 84 #26 of 158
Overall 81 67 77
  • ISRG ranked among 252 companies in Medical Devices and Diagnostics
  • SYK ranked among 252 companies in Medical Devices and Diagnostics
  • EW ranked among 252 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodISRGSYKEWSPY
1 month +5.6%+9.9%+24.0% -2.0%
3 months +12.4%-8.6%+17.0% -2.8%
6 months +5.3%+0.9%+31.7% +2.0%
Year to date -21.7%-11.9%+25.7% +10.6%
1 year -21.6%-17.1%+24.5% +12.2%
3 years +52.1%+9.4%+62.9% +68.1%
3 years, per year +15.0%+3.0%+17.7% +18.9%
5 years +25.0%+17.1%-7.6% +61.4%
5 years, per year +4.6%+3.2%-1.6% +10.1%
10 years +542.1%+180.5%+253.3% +248.5%
10 years, per year +20.4%+10.9%+13.5% +13.3%

Risk

MeasureISRGSYKEWSPY
Volatility, 1Y 36.1%32.9%25.5% 13.6%
Downside volatility, 1Y 38.4%32.8%24.7% 13.9%
Beta vs S&P 500, 1Y 0.920.280.58 1.00
Return / volatility, 1Y -0.60-0.520.96 0.90
Max drawdown, 5Y -49.9%-33.1%-54.3% -25.4%
From 52-week high -25.2%-20.1%0.0% -3.2%
52-week high $592.85$387.46$107.18 $779.14
52-week low $332.02$269.88$75.87 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleISRGSYKEW
P/E now vs peer median 52.4xmedian 26.5x 32.7xmedian 26.5x 60.9xmedian 26.5x
P/S now vs peer median 13.3xmedian 2.7x 4.5xmedian 2.7x 9.2xmedian 2.7x
EV/EBITDA now vs peer median 36.6xmedian 18.4x 38.6xmedian 18.4x 35.8xmedian 18.4x
P/FCF now vs peer median 42.7xmedian 25.4x 25.8xmedian 25.4x 43.3xmedian 25.4x
P/B now vs peer median 9.5xmedian 2.5x 5.0xmedian 2.5x 5.6xmedian 2.5x
PEG now vs peer median 2.04median 0.98 2.76median 0.98 -6.65median 0.98

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsISRGSYKEW
Revenue $11.58B $26.30B $6.67B
Gross profit $7.78B $17.18B $5.21B
Operating income $3.28B $5.43B $1.44B
Net income $2.97B $3.62B $1.02B
Free cash flow $3.60B $4.57B $1.42B
R&D $1.49B $64.80M $1.09B
EPS (diluted) $8.41 $9.42 $1.76
Cash & equivalents $2.98B $3.27B $3.11B
Total debt – $14.93B $598.80M
Shares (diluted) 351.60M 384.70M 577.60M
Enterprise value $133.02B $104.75B $44.79B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricISRGSYKEW
P/E 52.4x 32.7x 60.9x
P/FCF 42.7x 25.8x 43.3x
P/Operating cash flow 37.6x 21.6x 35.9x
P/S 13.3x 4.5x 9.2x
P/B 9.5x 5.0x 5.6x
P/Tangible book 10.3x 6.6x 6.3x
EV/EBITDA 36.6x 38.6x 35.8x
EV/EBIT 45.6x 23.8x 40.0x
EV/Revenue 12.9x 4.9x 8.6x
EV/FCF 41.6x 28.3x 40.5x
EV/Operating cash flow 36.6x 23.8x 33.6x
PEG (3Y EPS CAGR) 2.04 2.76 -6.65

Growth

14 metrics
MetricISRGSYKEW
Revenue growth (1Y) 20.5% 7.9% 13.4%
Revenue CAGR (3Y) 19.1% 9.8% 16.9%
Gross profit growth (1Y) 21.9% 10.1% 13.2%
Gross profit CAGR (3Y) 19.5% 10.9% 13.7%
Operating income growth (1Y) 16.6% 48.2% 1.1%
Operating income CAGR (3Y) 24.8% 16.4% 5.8%
Net income growth (1Y) 7.5% 23.1% -25.2%
Net income CAGR (3Y) 24.4% 11.9% -10.6%
EPS growth (1Y) 10.8% 23.7% -24.5%
EPS CAGR (3Y) 25.7% 11.8% -9.2%
Operating cash flow growth (1Y) 38.1% 12.7% 68.9%
Operating cash flow CAGR (3Y) 26.4% 19.6% 18.1%
Free cash flow growth (1Y) 58.4% 12.3% 77.1%
Free cash flow CAGR (3Y) 42.0% 21.2% 20.8%

Profitability

14 metrics
MetricISRGSYKEW
Gross margin 67.2% 65.3% 78.0%
EBITDA margin 35.3% 12.8% 24.2%
Operating margin 28.4% 20.7% 21.6%
Pretax margin 31.3% 19.5% 21.5%
Net margin 25.5% 13.8% 15.2%
FCF margin 31.1% 17.4% 21.3%
Operating cash flow margin 35.3% 20.7% 25.7%
Return on equity 17.3% -4.0% 9.4%
Return on assets 14.8% -2.0% 7.2%
Return on invested capital – 10.0% 8.7%
Return on capital employed 18.7% 13.2% 11.6%
Asset turnover 0.6x 0.6x 0.5x
Cash conversion (OCF / net income) 1.4x 1.5x 1.7x
Stock comp / revenue 7.2% 1.0% 2.6%

Financial Health

11 metrics
MetricISRGSYKEW
Debt / assets – 31.6% 4.2%
Debt / equity – 0.6x 0.1x
Net debt / EBITDA – 3.5x -2.5x
Debt / FCF – 3.3x 0.4x
Liabilities / assets 16.7% 50.4% 22.5%
Equity / assets 83.3% 49.6% 77.5%
Interest coverage – 9.3x –
Current ratio 3.3x 2.2x 4.6x
Quick ratio 2.3x 1.1x 3.5x
Cash ratio 1.6x 0.5x 2.9x
Altman Z-score 30.40 4.73 14.42

Shareholder Returns

7 metrics
MetricISRGSYKEW
Dividend yield – 1.1% –
Net buyback yield 2.8% – 0.9%
Shareholder yield 2.8% 1.1% 0.9%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusISRGSYKEW
Forward P/E 38.5xFY2026 19.6xFY2026 37.6xFY2026
EPS, next fiscal year $11.52FY2026 $15.79FY2026 $2.85FY2026
EPS growth, next FY +29.0%FY2026 +15.8%FY2026 +11.3%FY2026
EPS growth, the year after +4.5% +0.9% +12.6%
Revenue, next fiscal year $11.62BFY2026 $25.79BFY2026 $7.28BFY2026
Revenue growth, next FY +15.5%FY2026 +2.7%FY2026 +19.9%FY2026
Revenue growth, the year after +11.3% +16.5% -2.2%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersISRGSYKEW
Held by institutions 86.2% 80.3% 90.6%
Institutions holding 2,241 2,267 1,326
Change in shares held, QoQ +4.6% +3.1% +20.4%
Institutions buying 1,073 1,105 641
Institutions selling 879 852 456
Buyers to sellers 1.22 1.30 1.41

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ISRGSYKEW
ISRG 1.00 0.59 0.48
SYK 0.59 1.00 0.44
EW 0.48 0.44 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ISRG, SYK and EW?

Intuitive Surgical (ISRG) is the largest by market capitalisation: Intuitive Surgical (ISRG) $152.73B, Stryker (SYK) $118.57B, Edwards Lifesciences (EW) $61.58B.

Which stock is cheaper, ISRG, SYK and EW?

Stryker (SYK) trades on the lowest price-to-earnings ratio (Intuitive Surgical (ISRG) 51.6x, Stryker (SYK) 32.7x, Edwards Lifesciences (EW) 60.7x). On next year's consensus earnings, Stryker (SYK) is cheapest (Intuitive Surgical (ISRG) 38.5x, Stryker (SYK) 19.6x, Edwards Lifesciences (EW) 37.6x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Intuitive Surgical (ISRG) grew revenue fastest over the trailing twelve months: Intuitive Surgical (ISRG) +20.5%, Stryker (SYK) +7.9%, Edwards Lifesciences (EW) +13.4%.

Which company is more profitable?

Intuitive Surgical (ISRG) has the highest net margin (Intuitive Surgical (ISRG) 25.5%, Stryker (SYK) 13.8%, Edwards Lifesciences (EW) 15.2%). On return on invested capital, Stryker (SYK) leads (Stryker (SYK) 10.0%, Edwards Lifesciences (EW) 8.7%).

Which stock has performed better?

Over the past year Edwards Lifesciences (EW) returned the most: Intuitive Surgical (ISRG) -21.6%, Stryker (SYK) -17.1%, Edwards Lifesciences (EW) +24.5%. Over five years, Intuitive Surgical (ISRG) compounded fastest (Intuitive Surgical (ISRG) +4.6%/yr, Stryker (SYK) +3.2%/yr, Edwards Lifesciences (EW) -1.6%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Edwards Lifesciences (EW) has been the steadiest (Intuitive Surgical (ISRG) 36.1%, Stryker (SYK) 32.9%, Edwards Lifesciences (EW) 25.5%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ISRG, SYK and EW?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Intuitive Surgical (ISRG) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.